<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>with.MS</title>
	<link>http://with.ms</link>
	<description>Everything multiple sclerosis</description>
	<lastBuildDate>Tue, 31 Aug 2010 18:43:30 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.0.1" -->

	<item>
		<title>CBC News &#8211; Health &#8211; J.K. Rowling donates $16M for MS research</title>
		<description><![CDATA[CBC News &#8211; Health &#8211; J.K. Rowling donates $16M for MS research Author J.K. Rowling has donated the equivalent of $16.4 million Cdn to help set up a centre to research multiple sclerosis, the disease that led to the death of her mother. The creator of boy wizard Harry Potter said Tuesday that the Anne [...]]]></description>
		<link>http://with.ms/2010/08/cbc-news-health-j-k-rowling-donates-16m-for-ms-research/</link>
			</item>
	<item>
		<title>MS activity may vary with seasons – The Chart &#8211; CNN.com Blogs</title>
		<description><![CDATA[MS activity may vary with seasons – The Chart &#8211; CNN.com Blogs In the spring and summer months, some people with multiple sclerosis are at a two to three times greater risk for disease activity, according to research published Monday in the journal Neurology, the medical journal of the American Academy of Neurology. The study, [...]]]></description>
		<link>http://with.ms/2010/08/ms-activity-may-vary-with-seasons-%e2%80%93-the-chart-cnn-com-blogs/</link>
			</item>
	<item>
		<title>Researcher cautions trial for MS &#8216;liberation&#8217; therapy years away</title>
		<description><![CDATA[Researcher cautions trial for MS &#8216;liberation&#8217; therapy years away Saskatoon researcher Dr. Katherine Knox urged multiple sclerosis patients to have patience Wednesday, as a clinical trial of the so-called &#8220;liberation treatment&#8221; is years down the road, despite promised funding from the Saskatchewan government. The biggest difficulty her team faces, she said, is that they don&#8217;t [...]]]></description>
		<link>http://with.ms/2010/08/researcher-cautions-trial-for-ms-liberation-therapy-years-away/</link>
			</item>
	<item>
		<title>UPDATE: Elan: Test Results Could Help Determine PML Risk &#8211; WSJ.com</title>
		<description><![CDATA[UPDATE: Elan: Test Results Could Help Determine PML Risk &#8211; WSJ.com DUBLIN (Dow Jones)&#8211;Elan Corp. PLC (ELN) Tuesday announced results of a test that could help determine whether multiple sclerosis patients will develop a rare brain disease before they decide to take Elan and joint venture partner Biogen Idec Inc.&#8217;s (BIIB) drug Tysabri. According to [...]]]></description>
		<link>http://with.ms/2010/08/update-elan-test-results-could-help-determine-pml-risk-wsj-com/</link>
			</item>
	<item>
		<title>Jock Murray on CCSVI</title>
		<description><![CDATA[Neurologist Dr. Jock Murray on risks of CCSVI &#038; history of hype in MS (CBC Video)]]></description>
		<link>http://with.ms/2010/08/jock-murray-on-ccsvi/</link>
			</item>
	<item>
		<title>Real MS Voices</title>
		<description><![CDATA[Real MS Voices Imagine waking up and not knowing what your body will let you do, whether your sight will be blurry or your hands numb, whether you’ll even have the energy to climb out of bed. This is the reality for the 2.5 million people around the world who are living with MS. Real [...]]]></description>
		<link>http://with.ms/2010/08/real-ms-voices/</link>
			</item>
	<item>
		<title>Multiple sclerosis theory dealt a blow by studies &#8211; Los Angeles Times</title>
		<description><![CDATA[Multiple sclerosis theory dealt a blow by studies &#8211; Los Angeles Times Now research published online in the Annals of Neurology undermines the theory — called chronic cerebrospinal venous insufficiency by its creator, Italian researcher Paolo Zamboni. In one study, conducted by German scientists, ultrasound imaging tests of the veins around the brains and nervous [...]]]></description>
		<link>http://with.ms/2010/08/multiple-sclerosis-theory-dealt-a-blow-by-studies-los-angeles-times/</link>
			</item>
	<item>
		<title>Saskatchewan’s Wall vows to fund contentious MS treatment &#8211; The Globe and Mail</title>
		<description><![CDATA[Saskatchewan’s Wall vows to fund contentious MS treatment &#8211; The Globe and Mail In a striking departure from his political counterparts across the country, Saskatchewan Premier Brad Wall says his government will finance clinical trials of liberation therapy, a contentious experimental procedure for multiple sclerosis patients. “There isn’t unanimity on the issue, I understand that,” [...]]]></description>
		<link>http://with.ms/2010/07/saskatchewan%e2%80%99s-wall-vows-to-fund-contentious-ms-treatment-the-globe-and-mail/</link>
			</item>
	<item>
		<title>From M.S. Patients, Outcry for Unproved Treatment &#8211; NYTimes.com</title>
		<description><![CDATA[Talking about From M.S. Patients, Outcry for Unproved Treatment &#8211; NYTimes.com The new theory has taken off on the Internet, inspiring hope among patients, interest from some researchers and scorn from others. Supporters consider it an outside-the-box idea that could transform the treatment of the disease. Critics call it an outlandish notion that will probably [...]]]></description>
		<link>http://with.ms/2010/06/from-m-s-patients-outcry-for-unproved-treatment-nytimes-com/</link>
			</item>
	<item>
		<title>Proceed with caution on new MS treatment</title>
		<description><![CDATA[Talking about Proceed with caution on new MS treatment: Canada’s top medical journal &#8211; The Globe and Mail “There are a lot of people out there that have illnesses that are difficult to treat, impossible to cure,” Paul Hébert, editor-in-chief of the journal and co-author of the editorial, said in an interview. “The difficulty we [...]]]></description>
		<link>http://with.ms/2010/06/proceed-with-caution-on-new-ms-treatment/</link>
			</item>
</channel>
</rss>
